The effects of GSK239512 on lesion remyelination in a relapsing remitting MS population: Design of a phase 2a imaging study

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: cf7259395b21c8438f2e7abf7a1019b2a071218c
First added on: Apr 30, 2026